Zobrazeno 1 - 10
of 289
pro vyhledávání: '"Shulman DS"'
Autor:
Ilcisin L; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Han R; Children's Oncology Group, Monrovia, CA, USA., Krailo M; Children's Oncology Group, Arcadia, CA, USA.; Department of Population and Public Health Sciences Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Shulman DS; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Weil BR; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Weldon CB; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Umaretiya P; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA., Aziz-Bose R; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Greenzang KA; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Gorlick R; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reed DR; Division of Pediatric Solid Tumors, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Randall RL; Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, CA, USA., Nadel H; Division of Radiology, Lucille Packard Children's Hospital at Stanford University, Stanford, CA, USA., Binitie O; Department of Surgery, Moffitt Cancer Center, Tampa, FL, USA., Dubois SG; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Janeway KA; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Bona K; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Oct 01; Vol. 116 (10), pp. 1664-1674.
Autor:
Gikandi A; Harvard Medical School, Boston, Massachusetts, USA., Chi SN; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Yeo KK; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., O'Neill AF; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Shulman DS; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., DuBois SG; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Collins NB; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (8), pp. e7154.
Autor:
Campbell K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Posner A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Chen N; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Cavanaugh K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Bhushan K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., George S; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Klega K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Crompton B; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Dec; Vol. 70 (12), pp. e30681. Date of Electronic Publication: 2023 Sep 16.
Autor:
Olsen HE; Boston Children's Hospital, Boston, Massachusetts, USA., Liu KX; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, Massachusetts, USA., Frazier AL; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., O'Neill AF; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Nov; Vol. 70 (11), pp. e30652. Date of Electronic Publication: 2023 Aug 29.
Autor:
Yang DM; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX., Zhou Q; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Furman-Cline L; Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX., Cheng X; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Luo D; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Lai H; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center at Houston (UT Health), Houston, TX., Li Y; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Jin KW; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Yao B; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Leavey PJ; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX., Rakheja D; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX., Lo T; Children's Oncology Group Statistics and Data Center, Monrovia, CA., Hall D; Children's Oncology Group Statistics and Data Center, Monrovia, CA., Barkauskas DA; Children's Oncology Group Statistics and Data Center, Monrovia, CA.; Department of Population and Public Health Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, CA., Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Janeway K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Khanna C; Ethos Discovery, San Diego, CA., Gorlick R; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX., Menzies C; Children's Medical Center, Dallas, TX., Zhan X; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX., Xiao G; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Bioinformatics, The University of Texas Southwestern Medical Center, Dallas, TX., Skapek SX; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX., Xu L; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX., Klesse LJ; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Xie Y; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Bioinformatics, The University of Texas Southwestern Medical Center, Dallas, TX.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Sep; Vol. 7, pp. e2300104.
Autor:
Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Merriam P; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Choy E; Massachusetts General Hospital, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Guenther LM; St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Cavanaugh KL; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Kao PC; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Posner A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Bhushan K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Fairchild G; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Barker E; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Klega K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Stegmaier K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (14), pp. 15207-15216. Date of Electronic Publication: 2023 Jun 12.
Autor:
Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Kiwinda LV; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Edwards S; Boston Children's Hospital, Boston, MA, USA., Clinton CM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Hunt S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Greenspan L; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Lawler KD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Reaman G; US Food and Drug Administration, Silver Spring, MD, USA., Al-Sayegh H; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Bona K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., O'Neill AF; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Place AE; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Chi SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Ma C; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2021 Apr; Vol. 10 (7), pp. 2310-2318. Date of Electronic Publication: 2021 Mar 09.
Autor:
Shulman DS; Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Crompton BD; Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. BrianD_Crompton@DFCI.HARVARD.EDU.
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 2020; Vol. 1257, pp. 95-105.
Autor:
Neel DV; Harvard Medical School, Boston, Massachusetts, USA., Ma C; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Collins NB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Hornick JL; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Demetri GD; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute and Ludwig Center at Harvard, Boston, Massachusetts, USA., Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 170-178. Date of Electronic Publication: 2022 Jun 07.
Autor:
Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Chen S; Nationwide Children's Hospital, Columbus, OH, USA., Hall D; Children's Oncology Group, Monrovia, CA, USA., Nag A; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA., Thorner AR; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA., Lessnick SL; Nationwide Children's Hospital, Columbus, OH, USA., Stegmaier K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Krailo MD; Children's Oncology Group, Monrovia, CA, USA.; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Barkauskas DA; Children's Oncology Group, Monrovia, CA, USA.; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Church AJ; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA. briand_crompton@dfci.harvard.edu.; Broad Institute, Cambridge, MA, USA. briand_crompton@dfci.harvard.edu.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Dec; Vol. 127 (12), pp. 2220-2226. Date of Electronic Publication: 2022 Oct 11.